Evidence map›Paper›PMID 39516834›Full record

ArticleBMC medicine2024

Correction: Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination.

Dorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, Justyna Janocha-Litwin, Marek Sitko, Anna Piekarska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Barbara Sobala-Szczygieł, Magdalena Tudrujek-Zdunek and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Dorota Zarębska-Michaluk *Department of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, 25-317, Poland.
Michał Brzdęk *Collegium Medicumm, Jan Kochanowski University, Aleja IX Wieków Kielc 19A, Kielce, 25-317, Poland. michal.brzdek@gmail.com.ORCID http://orcid.org/0000-0002-1180-9230
Olga TroninaDepartment of Transplantology, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, Warsaw, Mazowieckie, 02-006, Poland.
Justyna Janocha-LitwinDepartment of Infectious Diseases and Hepatology, Wrocław Medical University, Wrocław, 50-367, Poland.
Marek SitkoDepartment of Infectious and Tropical Diseases, Jagiellonian University, Kraków, 31-088, Poland.
Anna PiekarskaDepartment of Infectious Diseases and Hepatology, Medical University of Łódź, Łódź, 90-419, Poland.
Jakub KlapaczyńskiDepartment of Internal Medicine and Hepatology, The National Institute of Medicine of the Ministry of Interior and Administration, Warsaw, 02-507, Poland.
Anna Parfieniuk-KowerdaDepartment of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, 15-089, Poland.
Barbara Sobala-SzczygiełDepartment of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Katowice, 40-635, Poland.
Magdalena Tudrujek-ZdunekDepartment of Infectious Diseases, Medical University of Lublin, Lublin, 20-059, Poland.
Łukasz LauransDepartment of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, Szczecin, 70-204, Poland.
Robert FlisiakDepartment of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, 15-089, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39516834
PMCPMC11546055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.